BTIG Upgrades Ocular Therapeutix (OCUL) to Buy, 'Turnaround Plan Starts to Take Form with the New Management Team'

January 19, 2018 6:51 AM

BTIG upgraded Ocular Therapeutix (NASDAQ: OCUL) from Neutral to Buy with a price target of $9.00.Analyst Dane ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found